Nothing Special   »   [go: up one dir, main page]

NO20020304L - Konserverte farmasoytiske preparater - Google Patents

Konserverte farmasoytiske preparater

Info

Publication number
NO20020304L
NO20020304L NO20020304A NO20020304A NO20020304L NO 20020304 L NO20020304 L NO 20020304L NO 20020304 A NO20020304 A NO 20020304A NO 20020304 A NO20020304 A NO 20020304A NO 20020304 L NO20020304 L NO 20020304L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preserved pharmaceutical
preserved
preparations
pharmaceutical
Prior art date
Application number
NO20020304A
Other languages
English (en)
Other versions
NO20020304D0 (no
Inventor
Atef Gayed
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20020304D0 publication Critical patent/NO20020304D0/no
Publication of NO20020304L publication Critical patent/NO20020304L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20020304A 1999-07-22 2002-01-21 Konserverte farmasoytiske preparater NO20020304L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22881599P 1999-07-22 1999-07-22
PCT/US2000/020040 WO2001007086A1 (en) 1999-07-22 2000-07-21 Preserved pharmaceutical formulations

Publications (2)

Publication Number Publication Date
NO20020304D0 NO20020304D0 (no) 2002-01-21
NO20020304L true NO20020304L (no) 2002-03-21

Family

ID=22858657

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020304A NO20020304L (no) 1999-07-22 2002-01-21 Konserverte farmasoytiske preparater

Country Status (21)

Country Link
US (1) US7109161B1 (no)
EP (1) EP1200128A1 (no)
JP (1) JP2003520777A (no)
KR (2) KR20070116181A (no)
CN (1) CN1371287A (no)
AU (1) AU777410C (no)
BR (1) BR0012674A (no)
CA (1) CA2378892C (no)
CZ (1) CZ2002265A3 (no)
EA (1) EA007070B1 (no)
EE (1) EE200200038A (no)
HK (1) HK1050317A1 (no)
HR (1) HRP20020160A2 (no)
HU (1) HUP0202235A3 (no)
IL (1) IL147756A (no)
NO (1) NO20020304L (no)
NZ (1) NZ516736A (no)
PL (1) PL353026A1 (no)
WO (1) WO2001007086A1 (no)
YU (1) YU4602A (no)
ZA (1) ZA200200743B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200200038A (et) 1999-07-22 2003-04-15 Aventis Pharmaceuticals Inc. Konservitud farmatseutilised preparaadid
US20020107469A1 (en) * 2000-11-03 2002-08-08 Charles Bolan Apheresis methods and devices
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
CA2543164A1 (en) * 2003-11-05 2005-05-19 Santarus, Inc. Combination of proton pump inhibitor and sleep aid
DE202004020676U1 (de) * 2004-03-10 2005-11-10 Bioceuticals Arzneimittel Ag Erythropoietin-Flüssigformulierung
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
WO2006023849A2 (en) 2004-08-20 2006-03-02 Mannkind Corporation Catalysis of diketopiperazine synthesis
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
CA2620758C (en) 2005-09-14 2016-06-21 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
AU2007216966C1 (en) 2006-02-22 2014-03-20 Mannkind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
BRPI0710287A2 (pt) 2006-04-18 2012-05-29 Ekr Therapeutics Inc composição farmacêutica, método para tratar um indivìduo quanto à pressão sangüìnea elevada, complexo de inclusão, e, métodos para tratar e evitar elevações agudas da pressão sangüinea em um indivìduo humano e para induzir a hipotensão em um indivìduo humano.
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
US20090069418A1 (en) * 2007-04-25 2009-03-12 Alkayed Nabil J Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation
DE102007054794A1 (de) * 2007-11-13 2009-05-14 Agilan Gmbh Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen
EP2240019A4 (en) * 2007-12-03 2011-11-16 Signum Biosciences Inc MIMETIC ACID COMPOUNDS FOR INHIBITING ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE
CN101980700A (zh) 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2570147B1 (en) 2008-06-13 2017-10-18 MannKind Corporation A dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
ES2400210T3 (es) 2008-10-02 2013-04-08 Mylan Inc. Método para preparar un laminado de adhesivo multicapa
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
US8925726B2 (en) * 2011-04-01 2015-01-06 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US20130011494A1 (en) * 2011-07-10 2013-01-10 Mohammad Rahimi Composition for treating decubitus ulcers in diabetic and non-diabetic patients
CN102993031B (zh) 2011-09-19 2014-03-26 北京桑普生物化学技术有限公司 一种制备芳基多氧烷基季铵类化合物的方法
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
JP6491658B2 (ja) 2013-07-18 2019-03-27 マンカインド コーポレイション 熱安定性乾燥粉末医薬組成物及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
DE102016000277A1 (de) 2016-01-15 2017-07-20 Beiersdorf Ag Kosmetische Zubereitungen enthaltend Benzethonium Chlorid und Diole
JP7220655B2 (ja) 2016-12-16 2023-02-10 ヴァーテラス ホールディングス エルエルシー 第四級アミン配合物及びその使用
US11364225B2 (en) * 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
US4053628A (en) 1971-05-12 1977-10-11 Fisons Limited Composition
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4506018A (en) 1982-12-30 1985-03-19 Becton, Dickinson And Company Blood diluent
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
ES2079320B1 (es) 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5611464A (en) 1995-05-30 1997-03-18 Ciba Geigy Corporation Container for preserving media in the tip of a solution dispenser
US5997893A (en) 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
US6022551A (en) 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
EE200200038A (et) 1999-07-22 2003-04-15 Aventis Pharmaceuticals Inc. Konservitud farmatseutilised preparaadid
EE200200037A (et) 1999-07-22 2003-04-15 Aventis Pharmaceuticals Inc. Mitmeannuselised erütropoetiinipreparaadid

Also Published As

Publication number Publication date
CN1371287A (zh) 2002-09-25
HK1050317A1 (zh) 2003-06-20
CA2378892A1 (en) 2001-02-01
IL147756A (en) 2005-12-18
PL353026A1 (en) 2003-10-06
IL147756A0 (en) 2002-08-14
EA200200072A1 (ru) 2003-02-27
JP2003520777A (ja) 2003-07-08
US7109161B1 (en) 2006-09-19
EP1200128A1 (en) 2002-05-02
NZ516736A (en) 2004-02-27
CZ2002265A3 (cs) 2002-08-14
AU777410B2 (en) 2004-10-14
KR20020032534A (ko) 2002-05-03
EE200200038A (et) 2003-04-15
AU6232500A (en) 2001-02-13
WO2001007086A1 (en) 2001-02-01
CA2378892C (en) 2008-07-15
NO20020304D0 (no) 2002-01-21
ZA200200743B (en) 2003-06-25
AU777410C (en) 2006-08-17
HUP0202235A2 (hu) 2002-11-28
EA007070B1 (ru) 2006-06-30
YU4602A (sh) 2005-06-10
HUP0202235A3 (en) 2004-05-28
BR0012674A (pt) 2002-09-17
HRP20020160A2 (en) 2003-10-31
KR20070116181A (ko) 2007-12-06

Similar Documents

Publication Publication Date Title
NO20020304L (no) Konserverte farmasoytiske preparater
NO20071303L (no) Farmasoytiske preparater
IS6040A (is) Valdekoxib efnablöndur
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20033556D0 (no) Farmasöytiske preparater
DK1210113T3 (da) Kombinerede vaccinepræparater
NO992339D0 (no) Farmas°ytiske formuleringer
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20015175L (no) Farmasöytisk sammensetning
NO20014526D0 (no) Farmasöytiske preparater omfattende metallkomplekser
ATE265852T1 (de) Geschmackskaschierte flüssige arzneizubereitungen
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
PT1173187E (pt) Preparacoes combinadas compreendendo derivados de antraciclina
DK1466615T3 (da) Farmaceutisk præparat
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
DE69926012D1 (de) Arzneizubereitungen
ATE246494T1 (de) Brausezubereitungen
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
FI4488U1 (fi) Farmaseuttinen koostumus
EE200100697A (et) Farmatseutiline kompleks
AR025867A1 (es) Formulacion portasdora farmaceutica
DE69906934D1 (de) Arzneizubereitungen
NO20004816D0 (no) Ny farmasøytisk formulering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application